Mesoporous Silica Nanoparticles as a Potential Platform for Vaccine Development against Tuberculosis
The increasing emergence of new strains of <i>Mycobacterium tuberculosis</i> (<i>Mtb</i>) highly resistant to antibiotics constitute a public health issue, since tuberculosis still constitutes the primary cause of death in the world due to bacterial infection. <i>Mtb &l...
Main Authors: | Sandra Montalvo-Quirós, María Vallet-Regí, Ainhoa Palacios, Juan Anguita, Rafael C. Prados-Rosales, Blanca González, Jose L. Luque-Garcia |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-12-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/12/12/1218 |
Similar Items
-
Mesoporous Silica Nanoparticles as Theranostic Antitumoral Nanomedicines
by: Alejandro Baeza, et al.
Published: (2020-10-01) -
Tuberculosis Progression Does Not Necessarily Equate with a Failure of Immune Control
by: David G. Russell
Published: (2019-06-01) -
Antimycobacterial Effect of Selenium Nanoparticles on Mycobacterium tuberculosis
by: Hector Estevez, et al.
Published: (2020-04-01) -
Functional Mesoporous Silica Nanocomposites: Biomedical Applications and Biosafety
by: Rafael R. Castillo, et al.
Published: (2019-02-01) -
Recent Advances Toward the Use of Mesoporous Silica Nanoparticles for the Treatment of Bacterial Infections
by: Castillo RR, et al.
Published: (2021-06-01)